Comparing Invokana vs Semaglutide
Invokana (canagliflozin) | Semaglutide |
|
---|
Invokana (canagliflozin) | Semaglutide |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Invokana is used to treat type 2 diabetes in adults and children 10 years and older and to reduce the risk of major adverse cardiovascular events or risk of end-stage kidney disease (ESKD) in adults... View more |
Prescription only
Semaglutide (Ozempic, Rybelsus) lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the... View more |
Related suggestions Cardiovascular Risk Reduction
Popular comparisons
|
|||||||
More about Invokana (canagliflozin) | More about Semaglutide | ||||||||
Ratings & Reviews | |||||||||
Invokana has an average rating of 5.8 out of 10 from a total of 257 ratings on Drugs.com. 46% of reviewers reported a positive effect, while 35% reported a negative effect. |
Semaglutide has an average rating of 6.9 out of 10 from a total of 2744 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Invokana side effects |
View all Semaglutide side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Invokana prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
N/A |
Ozempic, Rybelsus, Wegovy | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
13.1 hours |
168 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 392 drugs are known to interact with Invokana:
|
A total of 275 drugs are known to interact with Semaglutide:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
March 29, 2013 |
December 05, 2017 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.